Skip to content

Sleep and Circadian Contributions to Nighttime Blood Pressure

Sleep and Circadian Contributions to Nighttime Blood Pressure

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05656768
Acronym
SCN-BP
Enrollment
1427
Registered
2022-12-19
Start date
2023-06-01
Completion date
2028-12-30
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Circadian Rhythm, Hypertension, Sleep

Keywords

sleep, circadian rhythm, circadian misalignment, nocturnal hypertension, non-dipping blood pressure

Brief summary

Broadly, this study (SCN-BP) seeks to examine sleep and circadian factors that contribute to blood pressure levels at night.

Detailed description

SCN-BP is imbedded in a parent grant titled "Improving the Detection of Hypertension (IDH-MEGA)" and examines a variety of sleep (e.g., sleep duration, timing, and the presence of sleep disorder) and circadian factors in Aims 1 and 2. In Aim 3, the investigators will conduct a 30-hour constant routine protocol to directly examine endogenous circadian and blood pressure rhythms. Aims 1 and 2 are purely observation. The study design design described below pertains the intervention piece of this study (Aim 3).

Interventions

A constant routine protocol is used to directly examine markers of circadian rhythmicity (e.g., melatonin and core body temperature). A constant routine protocol requires an individual to remain in a dimly lit room, in a constant semi-recumbent posture, and remain awake for more than 24 hours. It is one of two gold-standard research protocols for examining circadian rhythms in humans.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant in the parent grant (IDH-MEGA)

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Change in MelatoninHourly samples obtained over 30 hoursMelatonin levels obtained from saliva samples
Change in Core body temperatureContinuous measurements over 30 hoursCore body temperature

Secondary

MeasureTime frameDescription
Change in Blood pressureMeasurements obtained every 30 minutes over 30 hoursSystolic and diastolic blood pressure obtained using an ambulatory blood pressure monitor

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORStephen J Thomas, PhD

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026